NDVCX
Price
$16.67
Change
+$0.13 (+0.79%)
Updated
Sep 3 closing price
Net Assets
2.28B
VSIIX
Price
$59.30
Change
+$0.37 (+0.63%)
Updated
Sep 3 closing price
Net Assets
68.3B
Interact to see
Advertisement

NDVCX vs VSIIX

NDVCX vs VSIIX Comparison Chart in %
View a ticker or compare two or three
VS
NDVCX vs. VSIIX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVCX is a Buy and VSIIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIIX has more cash in the bank: 68.3B vs. NDVCX (2.28B). VSIIX pays higher dividends than NDVCX: VSIIX (1.77) vs NDVCX (0.32). NDVCX was incepted earlier than VSIIX: NDVCX (15 years) vs VSIIX (27 years). NDVCX (1.98) is less costly to investors than VSIIX (0.05). NDVCX is a more actively managed with annual turnover of: 47.00 vs. VSIIX (25.00). NDVCX has a lower initial minimum investment than VSIIX: NDVCX (1000) vs VSIIX (5000000). VSIIX annual gain was more profitable for investors over the last year : 18.86 vs. NDVCX (1.65). VSIIX return over 5 years is better than : 43.44 vs. NDVCX (-14.87).
NDVCXVSIIXNDVCX / VSIIX
Total Expense Ratio1.970.053,940%
Annual Report Gross Expense Ratio1.980.053,960%
Fund Existence15 years27 years-
Gain YTD9.31916.10158%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.28B68.3B3%
Annual Yield % from dividends0.321.7718%
Returns for 1 year1.6518.869%
Returns for 3 years4.2546.459%
Returns for 5 years-14.8743.44-34%
Returns for 10 years27.26129.6321%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QMID30.570.33
+1.10%
WisdomTree U.S. Mid Cap Quality Gr
IYY188.342.02
+1.08%
iShares Dow Jones US ETF
BBH243.730.94
+0.39%
VanEck Biotech ETF
PBMR32.740.08
+0.25%
PGIM S&P 500 Buffer 20 ETF - Mar
MCN5.71-0.03
-0.52%
Madison Covered Call & Equity Strategy Fund